Capricor Therapeutics announced that it has successfully completed the U.S. FDA's Pre-License Inspection of its San Diego manufacturing facility for its lead therapy candidate, Deramiocel, aimed at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback